Carl Russell III

Indiana University/Purdue University MSTP Student

[Carl Russell III @CarlR_BME]

@2s0ckz @StemRad @ILSpaceAgency @DLR_en @LMSpace @NASA Incredible!!

[Carl Russell III @CarlR_BME]

It was wonderful to be in the presence of talented colleagues and supportive mentors at my first @ASNKidney #KidneyWk. Truly a wonderful experience made possible by kidney STARs and the peds nephrology group at @IUMedSchool

[Shweta Shah M.D; FASN @nefron1310]

Our full KidneyStars group, great poster session @ASNKidney #KidneyWk
@ameliamercado00 @SelinaHoelzel @CarlR_BME Jason and Anisha

[Shweta Shah M.D; FASN @nefron1310]

Great start to #KidneyWk with @ASNKidney #KidneyStars. Inspiring stories at the plenary session for future nephrologist @SelinaHoelzel @ameliamercado00 @bcmhouston Anisha @CarlR_BME

[Carl Russell III @CarlR_BME]

@anniebelch I look forward to seeing your work in Philly!

[Purdue Weldon School of Biomedical Engineering @PurdueBME]

#PurdueBME senior @CarlR_BME was named as one of seven Purdue Engineering Fellows last night. Each of the seven seniors will be awarded $20,000 each upon graduation and join the elite group of Purdue Engineering Fellows. Let's congratulate Carl on this amazing accomplishment!

[Purdue Weldon School of Biomedical Engineering @PurdueBME]

More great news from the @PurdueOUR Conference... #WeldonSchool students @CarlR_BME and Pei-Lun (Patricia) Chen from Hugh Lee's LIMR lab were awarded best abstract in the innovative design, technology, and entrepreneurship category!

[Purdue Engineering @PurdueEngineers]

A new treatment for strokes caused by bleeding in the brain that uses a magnetically controlled microrobot-enabled self-clearing catheter has been shown to be 86% effective in animal models. @PurdueBME's Hyowon "Hugh" Lee created the microdevice. https://t.co/fCxNbp3oh3

[BME EPICS @BmeEpics]

Our Vital Management Team presented in the Summit Showcase which they ended up placing 2nd at! Watch their video here!
https://t.co/ogRAGm46Uq

[BME EPICS @BmeEpics]

Happy Wednesday! The Pill Minder team is working hard at redesigning the locking mechanism part of their project! @EPICSPurdue #EPICSBME

[Carl Russell III @CarlR_BME]

Check out my research pitch submission! Like and share!

[Purdue UGRSP @purdueugrsp]

Carl Russell, @PurdueBME sophomore: "Systematic Review of Dietary Chronic Kidney Disease Applications" https://t.co/SzMAb0bHQZ

[Carl Russell III @CarlR_BME]

This is amazing news for ovarian cancer patients. Hopefully, the introduction to this treatment to the first presentation of ovarian cancer leads to better health outcomes.

[Target Ovarian Cancer @TargetOvarian]

🎉Today we’re celebrating @NICEComms’ landmark announcement that niraparib (Zejula®) will be made available to newly diagnosed women with advanced #OvarianCancer for the first time.  https://t.co/qPblcZ06Eb

[Carl Russell III @CarlR_BME]

@PurdueTimmyGH Amazing news. Another thing to note is that it would be the first mRNA based therapy to be approved by the FDA!

[Carl Russell III @CarlR_BME]

This video always makes me smile :) RIP Byamba https://t.co/N73j4plWZG

[Carl Russell III @CarlR_BME]

@HCCommentator1 @statnews The vaccine needs to be at around -70 F. Not your run of the mill fridge. Currently, it is definitely a critical supply chain issue for more impoverished and rural areas.

[Carl Russell III @CarlR_BME]

@TRDearden @DailyCaller A better analogy is someone receiving cancer treatment. Starve the bad so that the rest may live.

[Cook Medical @CookMedical]

On Veteran's Day, we are grateful for the brave people who have served our country.

[Carl Russell III @CarlR_BME]

@honeydipsofie Rewatching FMAB is the now the only thing in life that lets me experience emotions

[Carl Russell III @CarlR_BME]

@Tony__Heller That’s not how t-cells work: https://t.co/NXA9jYTwO2

[Carl Russell III @CarlR_BME]

@realPitBullDog @darakass That’s not how t-cells work https://t.co/NXA9jYTwO2